Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLA? 8mm, TiZr, NTP: medical device reports filed with FDA

4,010 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,010
device reports naming the brand
0% of all MAUDE reports · about 587 a year
546
reports, 12 months to August 2026
677 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

4,010 medical device reports received by FDA name the brand "BL, ? 3.3mm NC, SLA? 8mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

546 reports arrived in the 12 months to August 2026, down 19% from 677 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (63.2%), loss of osseointegration (32%) and fracture (1.6%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

076152Sep 2021: 31Oct 2021: 34Nov 2021: 45Dec 2021: 382022Jan 2022: 51Feb 2022: 17Mar 2022: 33Apr 2022: 41May 2022: 55Jun 2022: 44Jul 2022: 41Aug 2022: 76Sep 2022: 63Oct 2022: 42Nov 2022: 32Dec 2022: 752023Jan 2023: 62Feb 2023: 43Mar 2023: 42Apr 2023: 45May 2023: 52Jun 2023: 65Jul 2023: 54Aug 2023: 51Sep 2023: 30Oct 2023: 63Nov 2023: 33Dec 2023: 402024Jan 2024: 46Feb 2024: 32Mar 2024: 48Apr 2024: 48May 2024: 41Jun 2024: 41Jul 2024: 49Aug 2024: 64Sep 2024: 34Oct 2024: 141Nov 2024: 91Dec 2024: 582025Jan 2025: 46Feb 2025: 44Mar 2025: 31Apr 2025: 22May 2025: 0Jun 2025: 152Jul 2025: 39Aug 2025: 19Sep 2025: 35Oct 2025: 56Nov 2025: 43Dec 2025: 442026Jan 2026: 30Feb 2026: 28Mar 2026: 55Apr 2026: 42May 2026: 76Jun 2026: 53Jul 2026: 37Aug 2026: 47

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03476932019: 35720192020: 43020202021: 48120212022: 57020222023: 58020232024: 69320242025: 53120252026: 3682026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,010
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report94.3%3,781
Voluntary report0%0
User facility report0%0
Distributor report5.7%229
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,53363.2%62.8%
Loss of osseointegration1,28532%22.4%
Fracturea broken bone661.6%1.6%
Difficult to insertthe device was hard to insert210.5%0.4%
Unintended movement80.2%0%
Separation failure20%0.1%
Unstable20%0%
Activation, positioning or separation problem10%0%
Difficult to removethe device was hard to remove10%0%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,34033.4%
Painpain, site not specified86321.5%
Tissue damage49812.4%
Inflammationinflammation2867.1%
Hemorrhage/blood loss/bleeding2726.8%
Swelling/ edema1744.3%
Fistula1142.8%
Hyperresponsive to stimuli812%
Hypersensitivity/allergic reaction531.3%
Abscessa collection of pus511.3%
Swellingswelling360.9%
Failure of implant300.7%
Increased sensitivity190.5%
Inadequate osseointegration100.2%
Sinus perforation60.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLA? 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports4,0103,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer94.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLA? 8mm, TiZr, NTP reports

How many FDA reports name BL, ? 3.3mm NC, SLA? 8mm, TiZr, NTP?

4,010 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 546 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (63.2%), loss of osseointegration (32%), fracture (1.6%), difficult to insert (0.5%) and unintended movement (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (94.3%) and distributor reports (5.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLA? 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.